WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 14'2801 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 22'6551 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 17'465  17'308  17'151  16'992  16'831  15'454  13'214  11'192 
Births 246  246  246  246  246  258  305  257 
Surviving infants 244  244  244  244  244  255  301  248 
Pop. less than 5 years 1'225  1'226  1'224  1'227  1'235  1'333  1'466  1'182 
Pop. less than 15 years 3'736  3'763  3'797  3'844  3'899  4'294  3'959  3'701 
Female 15-49 years 4'593  4'586  4'571  4'549  4'519  4'117  3'561  2'913 

Number of reported case

(Click for retrospective incidence data for Chile)
Diphtheria 36  253 
Japanese encephalitis
Measles 1'958  3'844 
Mumps 876  950  891  825  1'243  2'352 
Pertussis 5'762  2'582  794  692  969  3'554  59  2'795 
Polio*
Rubella 14  743 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 12  10  22  31 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Chile)
Vaccine year result method % card seen                                                
BCG          92  91  96  95  100  93  94  96 
DTP1          90  94  93  94  96  98 
DTP3          90  94  92  94  95  91  95  93 
HepB_BD         
HepB3          90  94  92  94  95 
Hib3          90  94  92  94  95  91 
JapEnc         
MCV          90  91  93  93  96  97  97  94 
MCV2          74  77  84  89  89 
PCV1          90  83 
PCV3          82  55 
Pol3          90  93  92  94  95  91  95  93 
Rota1         
Rota_last         
Rubella1          90  91  93  93  96 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Chile)
BCG 92  91  95  95  99  93  94  96 
DTP1 90  98  93  94  96  98  98  97 
DTP3 90  94  92  94  95  91  95  93 
HepB3 90  94  92  94  95 
Hib3 90  94  92  94  95  91 
MCV 90  91  93  93  96  97  97  94 
PCV3 82  54 
Pol3 90  93  92  94  95  91  95  93 
Rota_last

Number of districts in the country 346  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 32
From 80 to 89% 17
From 50 to 79% 36
Less than 50% 8
Proportion of districts
not reporting DTP3 coverage
7
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6, 18 months; Yes
Influenza 6-23 months; > 65 years; Yes and risk groups
MMR 1, 6 years; Yes
MenACWY 2 doses
OPV 2, 4, 6, 18 months; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps 65 years; Yes
Tdap 6 years; and Y13 from 2013)

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  No  No  No  Yes  Yes 
What years does the MYP cover? number   2'011        Anual  Anual 
Nº of districts with microplans that include activities to raise immunization coverage number           28  28 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 346  346    340  346  345  341 
Nº districts with DTP3 coverage >=80% number 170  238  293  293  299  290  250 
% of districts with DTP3 coverage >=80% From 0 to 100% 49  69    86  86  84  73 
Nº districts with measles (MCV1) coverage >=95% number 84  105  163  163  190     
% of districts with MCV1 coverage >=95% From 0 to 100% 24  30    48  55     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes    No  No  No  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No             

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100    100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.